Regeneron Pharmaceuticals
REGN
$974.60
Share price
-0.37%
Change (1 day)
29.78%
Change (1 year)
Categories
Regeneron Pharmaceuticals (REGN) - Total assets
Total assets on the balance sheet as of March 2024 : $34.36 B
According to Regeneron Pharmaceuticals's latest financial reports the company's total assets are $34.36 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Regeneron Pharmaceuticals - Total assets on balance sheet (from 2001 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $33.08 B | 13.23% |
| 2022-12-31 | $29.21 B | 14.86% |
| 2021-12-31 | $25.43 B | 48.19% |
| 2020-12-31 | $17.16 B | 15.93% |
| 2019-12-31 | $14.80 B | 26.17% |
| 2018-12-31 | $11.73 B | 33.89% |
| 2017-12-31 | $8.76 B | 25.68% |
| 2016-12-31 | $6.97 B | 24.32% |
| 2015-12-31 | $5.60 B | 46.16% |
| 2014-12-31 | $3.83 B | 30.05% |
| 2013-12-31 | $2.95 B | 41.84% |
| 2012-12-31 | $2.08 B | 57.19% |
| 2011-12-31 | $1.32 B | 21.49% |
| 2010-12-31 | $1.08 B | 46.98% |
| 2009-12-31 | $0.74 B | 2.34% |
| 2008-12-31 | $0.72 B | -22.65% |
| 2007-12-31 | $0.93 B | 60.02% |
| 2006-12-31 | $0.58 B | 38.16% |
| 2005-12-31 | $0.42 B | -10.49% |
| 2004-12-31 | $0.47 B | -1.34% |
| 2003-12-31 | $0.47 B | 22.47% |
| 2002-12-31 | $0.39 B | -20.96% |
| 2001-12-31 | $0.49 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $171.96 B | 400.34% | 🇺🇸 USA |
 Novartis NVS | $94.33 B | 174.47% | 🇨🇭 Switzerland |
 Amgen AMGN | $97.15 B | 182.67% | 🇺🇸 USA |
 Sanofi SNY | $139.81 B | 306.80% | 🇫🇷 France |
 Biogen BIIB | $26.56 B | -22.70% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $3.82 B | -88.87% | 🇺🇸 USA |